{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:04:28Z","timestamp":1790373868592,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["1U19AI171292-01"],"award-info":[{"award-number":["1U19AI171292-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Killam doctoral Fellowship. Mitacs Elevate postdoctoral fellowship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Transmembrane Protease, Serine-2 (TMPRSS2) and TMPRSS11D are human proteases that enable SARS-CoV-2 and Influenza A\/B virus infections, but their biochemical mechanisms for facilitating viral cell entry remain unclear. We show these proteases spontaneously and efficiently cleave their own zymogen activation motifs, activating their broader protease activity on cellular substrates. We determine TMPRSS11D co-crystal structures with a native and an engineered activation motif, revealing insights into its autocleavage activation and distinct substrate binding cleft features. Leveraging this structural data, we develop nanomolar potency peptidomimetic inhibitors of TMPRSS11D and TMPRSS2. We show that a broad serine protease inhibitor that underwent clinical trials for TMPRSS2-targeted COVID-19 therapy, nafamostat mesylate, was rapidly cleaved by TMPRSS11D and converted to low activity derivatives. In this work, we develop mechanistic insights into human protease viral tropism and highlight both the strengths and limitations of existing human serine protease inhibitors, informing future drug discovery efforts targeting these proteases.<\/jats:p>","DOI":"10.1038\/s41467-025-59677-3","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T07:23:48Z","timestamp":1746861828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Structural basis of TMPRSS11D specificity and autocleavage activation"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6398-106X","authenticated-orcid":false,"given":"Bryan J.","family":"Fraser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan P.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e1ra","family":"Ferkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olzhas","family":"Ilyassov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"Lac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5733-598X","authenticated-orcid":false,"given":"Yen-Yen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma","family":"Seitova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9512-5265","authenticated-orcid":false,"given":"Yanjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Hejazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8242-4349","authenticated-orcid":false,"given":"Tristan M. G.","family":"Kenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda Z.","family":"Penn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4782-6016","authenticated-orcid":false,"given":"Aled","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6854-8003","authenticated-orcid":false,"given":"Richard","family":"Leduc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2032-7970","authenticated-orcid":false,"given":"Pierre-Luc","family":"Boudreault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8949-4374","authenticated-orcid":false,"given":"Gregg B.","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"B\u00e9nard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4971-3250","authenticated-orcid":false,"given":"Cheryl H.","family":"Arrowsmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,10]]},"reference":[{"key":"59677_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23498-x","volume":"12","author":"J Yang","year":"2021","unstructured":"Yang, J. et al. Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor. Nat. Commun. 12, 2996 (2021).","journal-title":"Nat. Commun."},{"key":"59677_CR2","doi-asserted-by":"crossref","unstructured":"Liu, J., Lu, F., Chen, Y., Plow, E. & Qin, J. Integrin mediates cell entry of the SARS-CoV-2 virus independent of cellular receptor ACE2. J. Biological Chem. 298, 101710 (2022).","DOI":"10.1016\/j.jbc.2022.101710"},{"key":"59677_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280 (2020).","journal-title":"Cell"},{"key":"59677_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-78402-2","volume":"10","author":"W Wruck","year":"2020","unstructured":"Wruck, W. & Adjaye, J. SARS-CoV-2 receptor ACE2 is co-expressed with genes related to transmembrane serine proteases, viral entry, immunity and cellular stress. Sci. Rep. 10, 1\u201314 (2020).","journal-title":"Sci. Rep."},{"key":"59677_CR5","doi-asserted-by":"publisher","first-page":"e024348","DOI":"10.1371\/journal.pone.0248348","volume":"16","author":"SN Neerukonda","year":"2021","unstructured":"Neerukonda, S. N. et al. Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2. PLoS One 16, e024348 (2021).","journal-title":"PLoS One"},{"key":"59677_CR6","doi-asserted-by":"crossref","unstructured":"Wettstein, L. et al. Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell culture. Commun. Biol. 5, 681 (2022).","DOI":"10.1038\/s42003-022-03613-4"},{"key":"59677_CR7","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41586-022-04661-w","volume":"605","author":"T Shapira","year":"2022","unstructured":"Shapira, T. et al. A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic. Nature 605, 340\u2013348 (2022).","journal-title":"Nature"},{"key":"59677_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciimmunol.abc3582","volume":"5","author":"R Zang","year":"2020","unstructured":"Zang, R. et al. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci. Immunol. 5, 1\u201314 (2020).","journal-title":"Sci. Immunol."},{"key":"59677_CR9","doi-asserted-by":"publisher","first-page":"10198","DOI":"10.1021\/jm5015633","volume":"57","author":"D Duch\u00eane","year":"2014","unstructured":"Duch\u00eane, D. et al. Analysis of subpocket selectivity and identification of potent selective inhibitors for matriptase and matriptase-2. J. Med Chem. 57, 10198\u201310204 (2014).","journal-title":"J. Med Chem."},{"key":"59677_CR10","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1021\/ml3000534","volume":"3","author":"\u00c9 Colombo","year":"2012","unstructured":"Colombo, \u00c9. et al. Design and synthesis of potent, selective inhibitors of matriptase. ACS Med Chem. Lett. 3, 530\u2013534 (2012).","journal-title":"ACS Med Chem. Lett."},{"key":"59677_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7776","volume":"6","author":"GL Zoratti","year":"2015","unstructured":"Zoratti, G. L. et al. Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling. Nat. Commun. 6, 6776 (2015).","journal-title":"Nat. Commun."},{"key":"59677_CR12","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1515\/hsz-2016-0131","volume":"397","author":"AS Murray","year":"2016","unstructured":"Murray, A. S., Varela, F. A. & List, K. Type II transmembrane serine proteases as potential targets for cancer therapy. Biol. Chem. 397, 815\u2013826 (2016).","journal-title":"Biol. Chem."},{"key":"59677_CR13","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/febs.13971","volume":"284","author":"LM Tanabe","year":"2017","unstructured":"Tanabe, L. M. & List, K. The role of type II transmembrane serine protease-mediated signaling in cancer. FEBS J. 284, 1421\u20131436 (2017).","journal-title":"FEBS J."},{"key":"59677_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0183507","volume":"12","author":"C Tseng","year":"2017","unstructured":"Tseng, C. et al. Matriptase shedding is closely coupled with matriptase zymogen activation and requires de novo proteolytic cleavage likely involving its own activity. PLoS One 12, 1\u201323 (2017).","journal-title":"PLoS One"},{"key":"59677_CR15","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41589-022-01059-7","volume":"18","author":"BJ Fraser","year":"2022","unstructured":"Fraser, B. J. et al. Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation. Nat. Chem. Biol. 18, 963\u2013971 (2022).","journal-title":"Nat. Chem. Biol."},{"key":"59677_CR16","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1182\/blood-2015-11-683110","volume":"127","author":"SM Le Gall","year":"2016","unstructured":"Le Gall, S. M. et al. Matriptase activation connects tissue factor-dependent coagulation initiation to epithelial proteolysis and signaling. Blood 127, 3260\u20133269 (2016).","journal-title":"Blood"},{"key":"59677_CR17","doi-asserted-by":"publisher","first-page":"12686","DOI":"10.1074\/jbc.RA120.014525","volume":"295","author":"C Zhang","year":"2020","unstructured":"Zhang, C. et al. Intracellular autoactivation of TMPRSS11A, an airway epithelial transmembrane serine protease. J. Biol. Chem. 295, 12686\u201312696 (2020).","journal-title":"J. Biol. Chem."},{"key":"59677_CR18","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1042\/BCJ20190375","volume":"476","author":"L Wang","year":"2019","unstructured":"Wang, L. et al. Autoactivation and calpain-1-mediated shedding of hepsin in human hepatoma cells. Biochem. J. 476, 2355\u20132369 (2019).","journal-title":"Biochem. J."},{"key":"59677_CR19","doi-asserted-by":"publisher","first-page":"102643","DOI":"10.1016\/j.jbc.2022.102643","volume":"298","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Transmembrane serine protease TMPRSS2 implicated in SARS-CoV-2 infection is autoactivated intracellularly and requires N-glycosylation for regulation. J. Biol. Chem. 298, 102643 (2022).","journal-title":"J. Biol. Chem."},{"key":"59677_CR20","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1158\/0008-5472.CAN-14-3297","volume":"75","author":"CJ Ko","year":"2015","unstructured":"Ko, C. J. et al. Androgen-induced TMPRSS2 activates matriptase and promotes extracellular matrix degradation, prostate cancer cell invasion, tumor growth, and metastasis. Cancer Res. 75, 2949\u20132960 (2015).","journal-title":"Cancer Res."},{"key":"59677_CR21","doi-asserted-by":"publisher","first-page":"7001","DOI":"10.1073\/pnas.2002589117","volume":"117","author":"S Matsuyama","year":"2020","unstructured":"Matsuyama, S. et al. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc. Natl Acad. Sci. USA 117, 7001\u20137003 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59677_CR22","doi-asserted-by":"publisher","first-page":"e1009233","DOI":"10.1371\/journal.ppat.1009233","volume":"17","author":"M Sasaki","year":"2021","unstructured":"Sasaki, M. et al. SARS-CoV-2 variants with mutations at the S1\/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells. PLoS Pathog. 17, e1009233 (2021).","journal-title":"PLoS Pathog."},{"key":"59677_CR23","doi-asserted-by":"publisher","first-page":"e202000786","DOI":"10.26508\/lsa.202000786","volume":"3","author":"D Bestle","year":"2020","unstructured":"Bestle, D. et al. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells. Life Sci. Alliance 3, e202000786 (2020).","journal-title":"Life Sci. Alliance"},{"key":"59677_CR24","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3390\/v13030384","volume":"13","author":"M Kishimoto","year":"2021","unstructured":"Kishimoto, M. et al. TMPRSS11D and TMPRSS13 activate the SARS-CoV-2 spike protein. Viruses 13, 384 (2021).","journal-title":"Viruses"},{"key":"59677_CR25","doi-asserted-by":"publisher","first-page":"108630","DOI":"10.1016\/j.celrep.2020.108630","volume":"34","author":"SM Gobeil","year":"2021","unstructured":"Gobeil, S. M. et al. D614G mutation alters SARS-CoV-2 spike conformation and enhances protease cleavage at the S1\/S2 junction. Cell Rep. 34, 108630 (2021).","journal-title":"Cell Rep."},{"key":"59677_CR26","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.molcel.2020.04.022","volume":"78","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M., Kleine-Weber, H. & Pohlmann, S. A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Mol. Cell 78, 779\u2013784 (2020).","journal-title":"Mol. Cell"},{"key":"59677_CR27","doi-asserted-by":"publisher","first-page":"9896","DOI":"10.1128\/JVI.01118-06","volume":"80","author":"E B\u00f6ttcher","year":"2006","unstructured":"B\u00f6ttcher, E. et al. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J. Virol. 80, 9896\u20139898 (2006).","journal-title":"J. Virol."},{"key":"59677_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0035108","volume":"7","author":"MJ Kesic","year":"2012","unstructured":"Kesic, M. J., Meyer, M., Bauer, R. & Jaspers, I. Exposure to ozone modulates human airway protease\/antiprotease balance contributing to increased influenza a infection. PLoS One 7, 1\u201312 (2012).","journal-title":"PLoS One"},{"key":"59677_CR29","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.bbrc.2014.06.109","volume":"450","author":"BS Hamilton","year":"2014","unstructured":"Hamilton, B. S. et al. Inhibition of influenza virus infection and hemagglutinin cleavage by the protease inhibitor HAI-2. Biochem. Biophys. Res. Commun. 450, 1070\u20131075 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"59677_CR30","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1111\/j.1742-4658.2007.05756.x","volume":"274","author":"OJP Kyrieleis","year":"2007","unstructured":"Kyrieleis, O. J. P. et al. Crystal structure of the catalytic domain of DESC1, a new member of the type II transmembrane serine proteinase family. FEBS J. 274, 2148\u20132160 (2007).","journal-title":"FEBS J."},{"key":"59677_CR31","doi-asserted-by":"crossref","unstructured":"Wang, H. et al. Structure-based discovery of dual pathway inhibitors for SARS-CoV-2 entry. Nat. Commun. 14, 7574 (2023).","DOI":"10.1038\/s41467-023-42527-5"},{"key":"59677_CR32","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.1016\/j.cell.2024.06.006","volume":"187","author":"M Mccallum","year":"2024","unstructured":"Mccallum, M. et al. Human coronavirus HKU1 recognition of the TMPRSS2 host receptor. Cell 187, 4231\u20134245 (2024).","journal-title":"Cell"},{"key":"59677_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/jb\/mvr131","volume":"151","author":"M Kato","year":"2012","unstructured":"Kato, M. et al. Hepatocyte growth factor activator inhibitor type 1 inhibits protease activity and proteolytic activation of human airway trypsin-like protease. J. Biochem. 151, 179\u2013187 (2012).","journal-title":"J. Biochem."},{"key":"59677_CR34","doi-asserted-by":"crossref","unstructured":"Zhuravel, S. V. et al. Nafamostat in hospitalized patients with moderate to severe COVID-19 pneumonia: a randomised Phase II clinical trial. EClinicalMedicine 41, 101169 (2021).","DOI":"10.1016\/j.eclinm.2021.101169"},{"key":"59677_CR35","doi-asserted-by":"publisher","first-page":"100849","DOI":"10.1016\/j.eclinm.2021.100849","volume":"35","author":"JD Gunst","year":"2021","unstructured":"Gunst, J. D. et al. Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial. EClinicalMedicine 35, 100849 (2021).","journal-title":"EClinicalMedicine"},{"key":"59677_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02518-7","volume":"20","author":"T Kinoshita","year":"2022","unstructured":"Kinoshita, T. et al. A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study). BMC Med. 20, 342 (2022).","journal-title":"BMC Med."},{"key":"59677_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0141169","volume":"10","author":"S Nimishakavi","year":"2015","unstructured":"Nimishakavi, S., Raymond, W. W., Gruenert, D. C. & Caughey, G. H. Divergent inhibitor susceptibility among airway lumen-accessible tryptic proteases. PLoS One 10, 1\u201317 (2015).","journal-title":"PLoS One"},{"key":"59677_CR38","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1128\/JVI.02320-12","volume":"87","author":"J Baron","year":"2013","unstructured":"Baron, J. et al. Matriptase, HAT, and TMPRSS2 activate the hemagglutinin of H9N2 Influenza A viruses. J. Virol. 87, 1811\u20131820 (2013).","journal-title":"J. Virol."},{"key":"59677_CR39","doi-asserted-by":"crossref","unstructured":"Bertram, S. et al. Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts. PLoS One 7, e35876 (2012).","DOI":"10.1371\/journal.pone.0035876"},{"key":"59677_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1003774","volume":"9","author":"B Hatesuer","year":"2013","unstructured":"Hatesuer, B. et al. Tmprss2 is essential for influenza H1N1 virus pathogenesis in mice. PLoS Pathog. 9, 1\u201310 (2013).","journal-title":"PLoS Pathog."},{"key":"59677_CR41","doi-asserted-by":"publisher","first-page":"5605","DOI":"10.1128\/JVI.00140-10","volume":"84","author":"E B\u00f6ttcher-Friebertsh\u00e4user","year":"2010","unstructured":"B\u00f6ttcher-Friebertsh\u00e4user, E. et al. Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. J. Virol. 84, 5605\u20135614 (2010).","journal-title":"J. Virol."},{"key":"59677_CR42","doi-asserted-by":"publisher","first-page":"6324","DOI":"10.1016\/j.vaccine.2009.03.029","volume":"27","author":"E B\u00f6ttcher","year":"2009","unstructured":"B\u00f6ttcher, E., Freuer, C., Steinmetzer, T., Klenk, H. D. & Garten, W. MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition. Vaccine 27, 6324\u20136329 (2009).","journal-title":"Vaccine"},{"key":"59677_CR43","doi-asserted-by":"publisher","first-page":"4116","DOI":"10.1021\/jm051272l","volume":"49","author":"T Steinmetzer","year":"2006","unstructured":"Steinmetzer, T. et al. Secondary Amides of Sulfonylated 3-Amidinophenylalanine. New Potent and Selective. J. Med. Chem. 49, 4116\u20134126 (2006).","journal-title":"J. Med. Chem."},{"key":"59677_CR44","doi-asserted-by":"publisher","first-page":"114437","DOI":"10.1016\/j.ejmech.2022.114437","volume":"238","author":"O Pilgram","year":"2022","unstructured":"Pilgram, O. et al. Improving the selectivity of 3-amidinophenylalanine-derived matriptase inhibitors. Eur. J. Med. Chem. 238, 114437 (2022).","journal-title":"Eur. J. Med. Chem."},{"key":"59677_CR45","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1042\/BJ20130101","volume":"452","author":"D Meyer","year":"2013","unstructured":"Meyer, D., Sielaff, F., Hammami, M. & Bottcher-Friebertshauser, E. B. Identification of the first synthetic inhibitors of the type II transmembrane serine protease TMPRSS2 suitable for inhibition of influenza virus activation. Biochem. J. 452, 331\u2013343 (2013).","journal-title":"Biochem. J."},{"key":"59677_CR46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1042\/BJ20041955","volume":"390","author":"S Herter","year":"2005","unstructured":"Herter, S. et al. Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers. Biochem. J. 390, 125\u2013136 (2005).","journal-title":"Biochem. J."},{"key":"59677_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.26508\/lsa.202000849","volume":"4","author":"A Ohno","year":"2021","unstructured":"Ohno, A. et al. Crystal structure of inhibitor-bound human MSPL that can activate high pathogenic avian influenza. Life Sci. Alliance 4, 1\u201311 (2021).","journal-title":"Life Sci. Alliance"},{"key":"59677_CR48","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1006\/jmbi.1999.3089","volume":"292","author":"D Lu","year":"1999","unstructured":"Lu, D. et al. Crystal structure of enteropeptidase light chain complexed with an analog of the trypsinogen activation peptide. J. Mol. Biol. 292, 361\u2013373 (1999).","journal-title":"J. Mol. Biol."},{"key":"59677_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34364-9","volume":"13","author":"X Yang","year":"2022","unstructured":"Yang, X. et al. Cryo-EM structures reveal the activation and substrate recognition mechanism of human enteropeptidase. Nat. Commun. 13, 6955 (2022).","journal-title":"Nat. Commun."},{"key":"59677_CR50","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1107\/S0907444900010763","volume":"56","author":"R Recacha","year":"2000","unstructured":"Recacha, R. et al. Structure of human \u03b1-thrombin complexed with RWJ-51438 at 1.7\u2009\u00c5: unusual perturbation of the 60A-60I insertion loop. Acta Crystallogr. D. Biol. Crystallogr. 56, 1395\u20131400 (2000).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"59677_CR51","doi-asserted-by":"publisher","first-page":"D368","DOI":"10.1093\/nar\/gkad1011","volume":"52","author":"M Varadi","year":"2024","unstructured":"Varadi, M. et al. AlphaFold protein structure database in 2024: providing structure coverage for over 214 million protein sequences. Nucleic Acids Res. 52, D368\u2013D375 (2024).","journal-title":"Nucleic Acids Res."},{"key":"59677_CR52","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"59677_CR53","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.2353\/ajpath.2010.090665","volume":"176","author":"Y Chen","year":"2010","unstructured":"Chen, Y. et al. TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells. Am. J. Pathol. 176, 2986\u20132996 (2010).","journal-title":"Am. J. Pathol."},{"key":"59677_CR54","doi-asserted-by":"crossref","unstructured":"Hoffmann, M. et al. Nafamostat mesylate blocks activation of SARS-CoV-2: new treatment option for COVID-19. Antimicrob. Agents Chemother. 64, e00754-20 (2020).","DOI":"10.1128\/AAC.00754-20"},{"key":"59677_CR55","doi-asserted-by":"crossref","unstructured":"Sasaki, M. et al. Host serine proteases TMPRSS2 and TMPRSS11D mediate proteolytic activation and trypsin-independent infection in group A rotaviruses. J. Virol. 95, e00398-21 (2021).","DOI":"10.1128\/JVI.00398-21"},{"key":"59677_CR56","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1124\/jpet.120.000219","volume":"379","author":"W Sun","year":"2020","unstructured":"Sun, W. et al. Targeting enteropeptidase with reversible covalent inhibitors to achieve metabolic benefits. J. Pharmacol. Exp. Therapeutics 379, 510\u2013521 (2020).","journal-title":"J. Pharmacol. Exp. Therapeutics"},{"key":"59677_CR57","doi-asserted-by":"publisher","first-page":"e2108728118","DOI":"10.1073\/pnas.2108728118","volume":"118","author":"M Mahoney","year":"2021","unstructured":"Mahoney, M. et al. A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells. PNAS 118, e2108728118 (2021).","journal-title":"PNAS"},{"key":"59677_CR58","doi-asserted-by":"publisher","first-page":"12969","DOI":"10.1021\/acs.jmedchem.4c00922","volume":"67","author":"M Desgagn\u00e9","year":"2024","unstructured":"Desgagn\u00e9, M. et al. Rational In Silico Design of Selective TMPRSS6 Peptidomimetic Inhibitors via Exploitation of the S2 Subpocket. J. Med. Chem. 67, 12969\u201312983 (2024).","journal-title":"J. Med. Chem."},{"key":"59677_CR59","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1107\/S0907444906019949","volume":"62","author":"W Minor","year":"2006","unstructured":"Minor, W., Cymborowski, M., Otwinowski, Z. & Chruszcz, M. HKL-3000: The integration of data reduction and structure solution - from diffraction images to an initial model in minutes. Acta Crystallogr. D. Biol. Crystallogr. 62, 859\u2013866 (2006).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"59677_CR60","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ Mccoy","year":"2007","unstructured":"Mccoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"59677_CR61","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1107\/S0907444904023510","volume":"60","author":"AA Vagin","year":"2004","unstructured":"Vagin, A. A. et al. REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use. Acta Crystallogr. D. Biol. Crystallogr. 60, 2184\u20132195 (2004).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"59677_CR62","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pro.3330","volume":"27","author":"CJ Williams","year":"2017","unstructured":"Williams, C. J. et al. MolProbity: more and better reference data for improved all-atom structure validation. Protein Sci. 27, 293\u2013315 (2017).","journal-title":"Protein Sci."},{"key":"59677_CR63","doi-asserted-by":"crossref","unstructured":"Sievers, F. et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. 7, 539 (2011).","DOI":"10.1038\/msb.2011.75"},{"key":"59677_CR64","doi-asserted-by":"publisher","first-page":"W320","DOI":"10.1093\/nar\/gku316","volume":"42","author":"X Robert","year":"2014","unstructured":"Robert, X. & Gouet, P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 42, W320\u2013W324 (2014).","journal-title":"Nucleic Acids Res."},{"key":"59677_CR65","doi-asserted-by":"crossref","unstructured":"Wu, T. et al. Three essential resources to improve differential scanning fluorimetry (DSF) experiments. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/2020.03.22.002543v1 (2020).","DOI":"10.1101\/2020.03.22.002543"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59677-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59677-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59677-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T08:02:45Z","timestamp":1746864165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59677-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,10]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["59677"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-59677-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.10.09.617371","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,10]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4351"}}